ARCHIVES

FEBT, For Pain Control, Shows Positive Results In Phase III

This article is from The Cancer Letter archive.

Vol. 29 No. 5 | May 26, 2006

Download PDF Visit The Full Archive

Related Articles

Cedars-Sinai Develops Criteria For FDG-PET In Breast Cancer

August 25, 2006

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

August 30, 2013

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011

Clinical Trials Approved By NCI

November 28, 2003

NCI Dispute GAO Charge That Cancer Control Contracts Were Mishandled

August 15, 1980

Comprehensive Centers Balk At “Requiring” All Control Programs To Be Funneled Through Them

December 5, 1975